3R Biotech specializes in HLVd testing using RT-PCR technology to ensure accurate detection of plant pathogens, minimizing false negatives and positives. The company provides tissue culture licensing to help cultivators maintain disease-free plant starts, enhancing growth and economic returns while ensuring compliance with regional genetics standards.
Funding
Funding not disclosed
Founders
Product
Problem
Cultivators face challenges in detecting Hop Latent Viroid (HLVd) and other plant pathogens, which can lead to significant crop losses and reduced profitability. Traditional testing methods may produce inaccurate results due to sample degradation or off-target amplification, resulting in false negatives or positives. Maintaining disease-free plant starts is crucial for ensuring healthy growth and compliance with regional genetics standards.
Solution
3R Biotech offers comprehensive plant health solutions, specializing in HLVd testing using RT-PCR technology. Their testing process incorporates a host control gene to minimize false negatives by ensuring the integrity of each reaction. The RT-PCR method also reduces the likelihood of false positives compared to RT-LAMP, by detecting two separate HLVd targets simultaneously. In addition to testing, 3R Biotech provides tissue culture licensing to help cultivators maintain disease-free plant starts, enhancing growth and economic returns.
Target Audience
The primary customers are cultivators, breeders, and nurseries, ranging from small to large scale, seeking to protect their plants from pathogens and maintain healthy, compliant crops.
Features
- HLVd testing using RT-PCR technology with a host control gene
- Detection of two separate HLVd targets simultaneously for enhanced accuracy
- Tissue culture licensing to maintain disease-free plant starts
- Prevention of false negatives due to sample degradation or failed PCR/LAMP reaction
- Reduced likelihood of false positives compared to RT-LAMP